Cutaneous T-cell lymphoma (CTCL) is a disease that begins in T cells — a type of white blood cell that normally helps your immune system fight off infection.
In CTCL, abnormal T cells travel to the skin, causing red, scaly patches, plaques or raised bumps that can easily be mistaken for common skin conditions like eczema or psoriasis. Most people are diagnosed in their 50s or 60s, though CTCL can occur at any age and is slightly more common in men than women.
Cutaneous Lymphoma Treatment Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
“There’s a lot of misinformation out there about this disease, so I find it rewarding to help patients understand what the condition is and how we can treat it. Most people live with CTCL for quite a long time, and I want to make sure those years are good years.”
— Dr. Michi Shinohara, dermatologist and co-director of the Fred Hutch Cutaneous Lymphoma Clinic
How CTCL is Treated
Depending on how much of the skin is involved, treatment options generally include:
- Skin-directed treatments: Topical ointments, light therapy (phototherapy) or targeted radiation.
- Systemic treatments: Oral or intravenous medications are often used if the disease advances beyond the skin.